Cargando…

Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study

SIMPLE SUMMARY: The analysis of circulating tumor cells (CTCs) as a “real-time liquid biopsy” in epithelial tumors for personalized medicine has received tremendous attention over the past years, with important clinical implications. In metastatic colorectal cancer (mCRC), the CellSearch(®) system h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mazard, Thibault, Cayrefourcq, Laure, Perriard, Françoise, Senellart, Hélène, Linot, Benjamin, de la Fouchardière, Christelle, Terrebonne, Eric, François, Eric, Obled, Stéphane, Guimbaud, Rosine, Mineur, Laurent, Fonck, Marianne, Daurès, Jean-Pierre, Ychou, Marc, Assenat, Eric, Alix-Panabières, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8231886/ https://www.ncbi.nlm.nih.gov/pubmed/34199250 http://dx.doi.org/10.3390/cancers13122966

Ejemplares similares

Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones
por: Cayrefourcq, Laure, et al.
Publicado: (2021)

S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells
por: Cayrefourcq, Laure, et al.
Publicado: (2019)

Autologous cell lines from circulating colon cancer cells captured from sequential liquid biopsies as model to study therapy-driven tumor changes
por: Soler, Alexandra, et al.
Publicado: (2018)

Association of COVID-19 Lockdown With the Tumor Burden in Patients With Newly Diagnosed Metastatic Colorectal Cancer
por: Thierry, Alain R., et al.
Publicado: (2021)

Sequential first-line treatment with nab-paclitaxel/gemcitabine and FOLFIRINOX in metastatic pancreatic adenocarcinoma: GABRINOX phase Ib-II controlled clinical trial
por: Assenat, E., et al.
Publicado: (2021)

Circulating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Circulating Tumor Cells and Circulating Tumor DNA Detection in Potentially Resectable Metastatic Colorectal Cancer: A Prospective Ancillary Study to the Unicancer Prodige-14 Trial
por: Bidard, François-Clément, et al.
Publicado: (2019)

KRAS G12D Mutation Subtype Is A Prognostic Factor for Advanced Pancreatic Adenocarcinoma
por: Bournet, Barbara, et al.
Publicado: (2016)

Dual targeting of HER1/EGFR and HER2 with cetuximab and trastuzumab in patients with metastatic pancreatic cancer after gemcitabine failure: results of the “THERAPY”phase 1-2 trial
por: Assenat, Eric, et al.
Publicado: (2015)

Clinical Relevance of Liquid Biopsy in Melanoma and Merkel Cell Carcinoma
por: Boyer, Magali, et al.
Publicado: (2020)

Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer
por: Balcik-Ercin, Pelin, et al.
Publicado: (2021)

Common variants in glucuronidation enzymes and membrane transporters as potential risk factors for colorectal cancer: a case control study
por: Falkowski, Sabrina, et al.
Publicado: (2017)

High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors
por: Smit, Daniel J., et al.
Publicado: (2020)

The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program
por: Aparicio, Thomas, et al.
Publicado: (2021)

Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal Cancer
por: Bui, Quang Loc, et al.
Publicado: (2022)

Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study
por: Francini, Sarah, et al.
Publicado: (2023)

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology
por: Vardas, Vasileios, et al.
Publicado: (2023)

Prognostic factors of BRAF V600E colorectal cancer with liver metastases: a retrospective multicentric study
por: Javed, Sahir, et al.
Publicado: (2022)

Stereotactic MR-Guided Adaptive Radiotherapy for Pancreatic Tumors: Updated Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2022)

Stereotactic MR-Guided Radiotherapy for Liver Metastases: First Results of the Montpellier Prospective Registry Study
por: Bordeau, Karl, et al.
Publicado: (2023)

The oncogenic and druggable hPG80 (Progastrin) is overexpressed in multiple cancers and detected in the blood of patients
por: You, Benoit, et al.
Publicado: (2019)

Impact du SARS-CoV2 sur la structuration de la prise en charge du cancer : exemple de la tenue des RCP de cancérologie en Occitanie
por: Grosclaude, Pascale, et al.
Publicado: (2020)

Intra-arterial hepatic beads loaded with irinotecan (DEBIRI) with mFOLFOX6 in unresectable liver metastases from colorectal cancer: a Phase 2 study
por: Pernot, Simon, et al.
Publicado: (2020)

In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood
por: Eslami-S, Zahra, et al.
Publicado: (2023)

FOLFIRINOX-R study design: a phase I/II trial of FOLFIRINOX plus regorafenib as first line therapy in patients with unresectable RAS-mutated metastatic colorectal cancer
por: Adenis, Antoine, et al.
Publicado: (2021)

Reverse transcription-quantitative polymerase chain reaction: description of a RIN-based algorithm for accurate data normalization
por: Ho-Pun-Cheung, Alexandre, et al.
Publicado: (2009)

“Circulating Tumor Cells: Finding Rare Events for a Huge Knowledge of Cancer Dissemination”
por: Alix-Panabières, Catherine
Publicado: (2020)

Publisher Correction: Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer
por: Bao-Caamano, Aida, et al.
Publicado: (2023)

Doxorubicin for the treatment of hepatocellular carcinoma: GAME OVER!
por: Guiu, Boris, et al.
Publicado: (2020)

Effects of a physical activity programme to prevent physical performance decline in onco‐geriatric patients: a randomized multicentre trial
por: Arrieta, Haritz, et al.
Publicado: (2019)

Machine Learning‐Assisted Evaluation of Circulating DNA Quantitative Analysis for Cancer Screening
por: Tanos, Rita, et al.
Publicado: (2020)

Bevacizumab plus FOLFIRI or FOLFOX in chemotherapy-refractory patients with metastatic colorectal cancer: a retrospective study
por: Lièvre, Astrid, et al.
Publicado: (2009)

RECIST and iRECIST criteria for the evaluation of nivolumab plus ipilimumab in patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: the GERCOR NIPICOL phase II study
por: Cohen, Romain, et al.
Publicado: (2020)

Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers
por: Evrard, Camille, et al.
Publicado: (2022)

Cell lines from circulating tumor cells
por: Pantel, Klaus, et al.
Publicado: (2015)

Liquid biopsy: from discovery to clinical implementation
por: Alix‐Panabières, Catherine, et al.
Publicado: (2021)

Crucial roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Pantel, Klaus, et al.
Publicado: (2022)

Mechanobiology and survival strategies of circulating tumor cells: a process towards the invasive and metastatic phenotype
por: Kurma, Keerthi, et al.
Publicado: (2023)

Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial
por: Bourdel-Marchasson, Isabelle, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_i48sjpvdq665dpobga59tnt99m